| Identification | Back Directory |  [Name]
  TIN PROTOPORPHYRIN IX DICHLORIDE |  [CAS]
  14325-05-4 |  [Synonyms]
  SnPPIX Nsc267099 TINPROTOPORPHYRIN tin protoporphyrin IX TIN PROTOPORPHYRIN IX DICHLORIDE Tin Protoporphyrin IX (chloride) Stannate(2-) dichloro[7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid] |  [Molecular Formula]
  C34H36Cl2N4O4Sn |  [MDL Number]
  MFCD00673909 |  [MOL File]
  14325-05-4.mol |  [Molecular Weight]
  754.29 |  
 | Chemical Properties | Back Directory |  [storage temp. ]
  Store at RT |  [solubility ]
  Soluble to 25 mM in 1eq. NaOH and to 5 mM in DMSO |  [form ]
  Dark red to violet solid. |  [color ]
  Brown to reddish brown |  
 | Hazard Information | Back Directory |  [Uses]
  Heme oxygenase (HO) converts protoheme to biliverdin, which in turn is enzymatically metabolized to bilirubin . While HO-2 is constitutively expressed, HO-1 can be induced by its heme substrate as well as by heavy metals, oxidizing agents, and other environmental stresses. TIN PROTOPORPHYRIN IX DICHLORIDE(SnPPIX) is a synthetic heme analog that selectively inhibits HO-1 (Ki = 11 nM) over HO-2 (IC50 = 7.5 μM). It also weakly inhibits endothelial nitric oxide synthase and soluble guanylyl cyclase (IC50s = 35 and 30 nM, respectively). SnPPIX prevents hyperbilirubinemia in neonates by blocking HO-1 activity that increases postnatally. It is rapidly cleared from plasma and persists in certain tissues, including kidney, liver, and spleen. SnPPIX is commonly used as a tool to study the role of HO-1 activity in cells and in animals.[Cayman Chemical]
 |  [in vivo]
 
 Tin protoporphyrin IX dichloride (intraperitoneal injection; 5 mg/kg; at 0, 7, 15, and 20 days) alone or combines with Gemcitabine significantly reduced the weight of pancreatic tumors (P < 0.05), decreases metastasis and improved the efficacy of Gemcitabine treatment[1]. | Animal Model: | Male and female athymic nude mice with PDAC cell-derived xenograft tumors[1] |  | Dosage: | 5 mg/kg |  | Administration: | Intraperitoneal injection; at days 1, 4, 6, 8, 11, 13, 15, 18, and 20  |  | Result: | Inhibited tumor growth and sensitized tumors to chemotherapy (Gemcitabine). |  
  |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    
                        
                            | Company Name: | 
                            
                                Alfa Chemistry  
                             | 
                         
                        
                            | Tel: | 
                            1-516-6625404  | 
                         
                        
                        
                            | Website: | 
                            https://www.alfa-chemistry.com | 
                         
                    
                 
                
                
                
                
                
                
                
             |